APO RESEARCH · REPORT
Synthetic Biology Technology
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
Product & engineering
Understand the product.
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
Selected research
Market Analysis & Forecast
Global Synthetic Biology Technology Market Analysis and Forecast 2026-2032
Market perspective
Synthetic biology is a new way of applying biological science to daily life. The Royal Society in London, UK believes that synthetic biology combines knowledge and tools in other fields, including systems biology, genetic engineering, mechanical engineering, electromechanical engineering, information theory, physics, nanotechnology and computer simulation and many more.
The North American market is the most important consumer region, accounting for 48.23% of the global total in 2019, with sales of US$421.30 million. The European market is second only to the North American market, accounting for 21.12% of the global total, with sales of US$184.52 million. The leading products represented by Genscript Biotech, Integrated DNA, Ginkgo Bioworks, Agilent, Thermo Fisher, etc. occupy a leading position in the international market, accounting for 45.54% of the global market share.
Report Includes
Read the full market overview
This report presents an overview of global market for Synthetic Biology Technology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Synthetic Biology Technology, also provides the revenue of main regions and countries. Of the upcoming market potential for Synthetic Biology Technology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Synthetic Biology Technology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Synthetic Biology Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Synthetic Biology Technology revenue, projected growth trends, production technology, application and end-user industry.
Synthetic Biology Technology Segment by Company
Genscript Biotech
Integrated DNA
Ginkgo Bioworks
Agilent
Thermo Fisher
BBI
Eurofins Genomics
Genewiz
Synthetic Genomics
Twist Bioscience
SBS Genetech
ATUM
Synthetic Biology Technology Segment by Type
Gene Synthesis
Oligonucleotide Synthesis
Bioinformatics Analysis
DNA Assembly
Synthetic Biology Technology Segment by Application
Medicine
Chemical Industry
Agriculture
Synthetic Biology Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Synthetic Biology Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Synthetic Biology Technology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Biology Technology revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Synthesis
- Oligonucleotide Synthesis
- Bioinformatics Analysis
- DNA Assembly
Applications
- Medicine
- Chemical Industry
- Agriculture
Companies covered
- Genscript Biotech
- Integrated DNA
- Ginkgo Bioworks
- Agilent
- Thermo Fisher
- BBI
- Eurofins Genomics
- Genewiz
- Synthetic Genomics
- Twist Bioscience
- SBS Genetech
- ATUM
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Synthetic Biology Technology Market by Type
- 1.2.1 Global Synthetic Biology Technology Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Gene Synthesis
- 1.2.3 Oligonucleotide Synthesis
- 1.2.4 Bioinformatics Analysis
- 1.2.5 DNA Assembly
- 1.3 Synthetic Biology Technology Market by Application
- 1.3.1 Global Synthetic Biology Technology Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medicine
- 1.3.3 Chemical Industry
- 1.3.4 Agriculture
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Synthetic Biology Technology Market Dynamics
- 2.1 Synthetic Biology Technology Industry Trends
- 2.2 Synthetic Biology Technology Industry Drivers
- 2.3 Synthetic Biology Technology Industry Opportunities and Challenges
- 2.4 Synthetic Biology Technology Industry Restraints
3 Global Growth Perspective
- 3.1 Global Synthetic Biology Technology Market Perspective (2021-2032)
- 3.2 Global Synthetic Biology Technology Growth Trends by Region
- 3.2.1 Global Synthetic Biology Technology Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Synthetic Biology Technology Market Size by Region (2021-2026)
- 3.2.3 Global Synthetic Biology Technology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Synthetic Biology Technology Revenue by Players
- 4.1.1 Global Synthetic Biology Technology Revenue by Players (2021-2026)
- 4.1.2 Global Synthetic Biology Technology Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Synthetic Biology Technology Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Synthetic Biology Technology Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Synthetic Biology Technology Key Players Headquarters & Area Served
- 4.4 Global Synthetic Biology Technology Players, Product Type & Application
- 4.5 Global Synthetic Biology Technology Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Synthetic Biology Technology Market CR5 and HHI
- 4.6.3 2025 Synthetic Biology Technology Tier 1, Tier 2, and Tier 3
5 Synthetic Biology Technology Market Size by Type
- 5.1 Global Synthetic Biology Technology Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Synthetic Biology Technology Revenue by Type (2021-2032)
- 5.3 Global Synthetic Biology Technology Revenue Market Share by Type (2021-2032)
6 Synthetic Biology Technology Market Size by Application
- 6.1 Global Synthetic Biology Technology Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Synthetic Biology Technology Revenue by Application (2021-2032)
- 6.3 Global Synthetic Biology Technology Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Genscript Biotech
- 7.1.1 Genscript Biotech Company Information
- 7.1.2 Genscript Biotech Business Overview
- 7.1.3 Genscript Biotech Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.1.4 Genscript Biotech Synthetic Biology Technology Product Portfolio
- 7.1.5 Genscript Biotech Recent Developments
- 7.2 Integrated DNA
- 7.2.1 Integrated DNA Company Information
- 7.2.2 Integrated DNA Business Overview
- 7.2.3 Integrated DNA Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.2.4 Integrated DNA Synthetic Biology Technology Product Portfolio
- 7.2.5 Integrated DNA Recent Developments
- 7.3 Ginkgo Bioworks
- 7.3.1 Ginkgo Bioworks Company Information
- 7.3.2 Ginkgo Bioworks Business Overview
- 7.3.3 Ginkgo Bioworks Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.3.4 Ginkgo Bioworks Synthetic Biology Technology Product Portfolio
- 7.3.5 Ginkgo Bioworks Recent Developments
- 7.4 Agilent
- 7.4.1 Agilent Company Information
- 7.4.2 Agilent Business Overview
- 7.4.3 Agilent Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.4.4 Agilent Synthetic Biology Technology Product Portfolio
- 7.4.5 Agilent Recent Developments
- 7.5 Thermo Fisher
- 7.5.1 Thermo Fisher Company Information
- 7.5.2 Thermo Fisher Business Overview
- 7.5.3 Thermo Fisher Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.5.4 Thermo Fisher Synthetic Biology Technology Product Portfolio
- 7.5.5 Thermo Fisher Recent Developments
- 7.6 BBI
- 7.6.1 BBI Company Information
- 7.6.2 BBI Business Overview
- 7.6.3 BBI Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.6.4 BBI Synthetic Biology Technology Product Portfolio
- 7.6.5 BBI Recent Developments
- 7.7 Eurofins Genomics
- 7.7.1 Eurofins Genomics Company Information
- 7.7.2 Eurofins Genomics Business Overview
- 7.7.3 Eurofins Genomics Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.7.4 Eurofins Genomics Synthetic Biology Technology Product Portfolio
- 7.7.5 Eurofins Genomics Recent Developments
- 7.8 Genewiz
- 7.8.1 Genewiz Company Information
- 7.8.2 Genewiz Business Overview
- 7.8.3 Genewiz Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.8.4 Genewiz Synthetic Biology Technology Product Portfolio
- 7.8.5 Genewiz Recent Developments
- 7.9 Synthetic Genomics
- 7.9.1 Synthetic Genomics Company Information
- 7.9.2 Synthetic Genomics Business Overview
- 7.9.3 Synthetic Genomics Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.9.4 Synthetic Genomics Synthetic Biology Technology Product Portfolio
- 7.9.5 Synthetic Genomics Recent Developments
- 7.10 Twist Bioscience
- 7.10.1 Twist Bioscience Company Information
- 7.10.2 Twist Bioscience Business Overview
- 7.10.3 Twist Bioscience Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.10.4 Twist Bioscience Synthetic Biology Technology Product Portfolio
- 7.10.5 Twist Bioscience Recent Developments
- 7.11 SBS Genetech
- 7.11.1 SBS Genetech Company Information
- 7.11.2 SBS Genetech Business Overview
- 7.11.3 SBS Genetech Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.11.4 SBS Genetech Synthetic Biology Technology Product Portfolio
- 7.11.5 SBS Genetech Recent Developments
- 7.12 ATUM
- 7.12.1 ATUM Company Information
- 7.12.2 ATUM Business Overview
- 7.12.3 ATUM Synthetic Biology Technology Revenue and Gross Margin (2021-2026)
- 7.12.4 ATUM Synthetic Biology Technology Product Portfolio
- 7.12.5 ATUM Recent Developments
8 North America
- 8.1 North America Synthetic Biology Technology Revenue (2021-2032)
- 8.2 North America Synthetic Biology Technology Revenue by Type (2021-2032)
- 8.2.1 North America Synthetic Biology Technology Revenue by Type (2021-2026)
- 8.2.2 North America Synthetic Biology Technology Revenue by Type (2027-2032)
- 8.3 North America Synthetic Biology Technology Revenue Share by Type (2021-2032)
- 8.4 North America Synthetic Biology Technology Revenue by Application (2021-2032)
- 8.4.1 North America Synthetic Biology Technology Revenue by Application (2021-2026)
- 8.4.2 North America Synthetic Biology Technology Revenue by Application (2027-2032)
- 8.5 North America Synthetic Biology Technology Revenue Share by Application (2021-2032)
- 8.6 North America Synthetic Biology Technology Revenue by Country
- 8.6.1 North America Synthetic Biology Technology Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Synthetic Biology Technology Revenue by Country (2021-2026)
- 8.6.3 North America Synthetic Biology Technology Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Synthetic Biology Technology Revenue (2021-2032)
- 9.2 Europe Synthetic Biology Technology Revenue by Type (2021-2032)
- 9.2.1 Europe Synthetic Biology Technology Revenue by Type (2021-2026)
- 9.2.2 Europe Synthetic Biology Technology Revenue by Type (2027-2032)
- 9.3 Europe Synthetic Biology Technology Revenue Share by Type (2021-2032)
- 9.4 Europe Synthetic Biology Technology Revenue by Application (2021-2032)
- 9.4.1 Europe Synthetic Biology Technology Revenue by Application (2021-2026)
- 9.4.2 Europe Synthetic Biology Technology Revenue by Application (2027-2032)
- 9.5 Europe Synthetic Biology Technology Revenue Share by Application (2021-2032)
- 9.6 Europe Synthetic Biology Technology Revenue by Country
- 9.6.1 Europe Synthetic Biology Technology Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Synthetic Biology Technology Revenue by Country (2021-2026)
- 9.6.3 Europe Synthetic Biology Technology Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Synthetic Biology Technology Revenue (2021-2032)
- 10.2 China Synthetic Biology Technology Revenue by Type (2021-2032)
- 10.2.1 China Synthetic Biology Technology Revenue by Type (2021-2026)
- 10.2.2 China Synthetic Biology Technology Revenue by Type (2027-2032)
- 10.3 China Synthetic Biology Technology Revenue Share by Type (2021-2032)
- 10.4 China Synthetic Biology Technology Revenue by Application (2021-2032)
- 10.4.1 China Synthetic Biology Technology Revenue by Application (2021-2026)
- 10.4.2 China Synthetic Biology Technology Revenue by Application (2027-2032)
- 10.5 China Synthetic Biology Technology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Synthetic Biology Technology Revenue (2021-2032)
- 11.2 Asia Synthetic Biology Technology Revenue by Type (2021-2032)
- 11.2.1 Asia Synthetic Biology Technology Revenue by Type (2021-2026)
- 11.2.2 Asia Synthetic Biology Technology Revenue by Type (2027-2032)
- 11.3 Asia Synthetic Biology Technology Revenue Share by Type (2021-2032)
- 11.4 Asia Synthetic Biology Technology Revenue by Application (2021-2032)
- 11.4.1 Asia Synthetic Biology Technology Revenue by Application (2021-2026)
- 11.4.2 Asia Synthetic Biology Technology Revenue by Application (2027-2032)
- 11.5 Asia Synthetic Biology Technology Revenue Share by Application (2021-2032)
- 11.6 Asia Synthetic Biology Technology Revenue by Country
- 11.6.1 Asia Synthetic Biology Technology Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Synthetic Biology Technology Revenue by Country (2021-2026)
- 11.6.3 Asia Synthetic Biology Technology Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Synthetic Biology Technology Revenue (2021-2032)
- 12.2 SAMEA Synthetic Biology Technology Revenue by Type (2021-2032)
- 12.2.1 SAMEA Synthetic Biology Technology Revenue by Type (2021-2026)
- 12.2.2 SAMEA Synthetic Biology Technology Revenue by Type (2027-2032)
- 12.3 SAMEA Synthetic Biology Technology Revenue Share by Type (2021-2032)
- 12.4 SAMEA Synthetic Biology Technology Revenue by Application (2021-2032)
- 12.4.1 SAMEA Synthetic Biology Technology Revenue by Application (2021-2026)
- 12.4.2 SAMEA Synthetic Biology Technology Revenue by Application (2027-2032)
- 12.5 SAMEA Synthetic Biology Technology Revenue Share by Application (2021-2032)
- 12.6 SAMEA Synthetic Biology Technology Revenue by Country
- 12.6.1 SAMEA Synthetic Biology Technology Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Synthetic Biology Technology Revenue by Country (2021-2026)
- 12.6.3 SAMEA Synthetic Biology Technology Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst